These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Controlling the mass action of alpha-synuclein in Parkinson's disease. Kim C; Lee SJ J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382 [TBL] [Abstract][Full Text] [Related]
15. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease. Ferrer I; Perez E; Dalfó E; Barrachina M Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347 [TBL] [Abstract][Full Text] [Related]
16. Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease? Michel PP; Ruberg M; Hirsch E Sci STKE; 2006 Apr; 2006(332):pe19. PubMed ID: 16639033 [TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein and Parkinson's disease: a proteomic view. Fasano M; Lopiano L Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054 [TBL] [Abstract][Full Text] [Related]
18. Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra. Noureddine MA; Li YJ; van der Walt JM; Walters R; Jewett RM; Xu H; Wang T; Walter JW; Scott BL; Hulette C; Schmechel D; Stenger JE; Dietrich F; Vance JM; Hauser MA Mov Disord; 2005 Oct; 20(10):1299-309. PubMed ID: 15966006 [TBL] [Abstract][Full Text] [Related]
19. Gene-environment interactions in Parkinson's disease. Ross CA; Smith WW Parkinsonism Relat Disord; 2007; 13 Suppl 3():S309-15. PubMed ID: 18267256 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. Hatano T; Kubo S; Sato S; Hattori N J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]